It is currently Fri Nov 17, 2017 3:06 pm

News News of Sativex

Site map of Sativex » Forum : Sativex

A cannabis derived drug which has been approved in some countries to treat muscle spasticity.

Sativex long-term use: an open-label trial

Sativex long-term use: an open-label trial in patients with spasticity due to MS

Image

Summary: This new study from a research group in Scotland assesses the long term safety profile of regular Sativex use for spasticity in MS.

The report, which follows-up 146 patients using treatment for a mean duration of 334 days, administering a mean of 7.3 actuations per day, found that 36% withdrew in the first year, either due to adverse events of ...
Read more : Sativex long-term use: an open-label trial | Views : 2820 | Replies : 0


Progress on new cannabis based treatment for MS patients

Progress on new cannabis based treatment for MS patients in Eire

Image

Efforts at making a medication derived from cannabis available for persons with Multiple Sclerosis have moved a step closer, with the completion of the European Mutual Recognition Procedure.

Galway West Deputy Seán Kyne confirmed the news this week, saying that he had a number of representations made to him by constituents concerned at the lack of availability in Ireland of Sativex, a cannabis-derived ...
Read more : Progress on new cannabis based treatment for MS patients | Views : 1627 | Replies : 11


Sativex® mutual recognition procedure closes

Sativex® mutual recognition procedure closes with recommendation for approval in ten european countries

Image


GW Pharmaceuticals plc and Almirall S.A. today announce the successful completion of the European Mutual Recognition Procedure (MRP) for Sativex® oromucosal spray in the treatment of spasticity due to Multiple Sclerosis (MS).

Following previous positive regulatory submissions in the UK, Spain, Germany, Italy, Denmark Sweden, Austria, Czech Republic, a MRP application was made to expand the availability of Sativex® to ten ...
Read more : Sativex® mutual recognition procedure closes | Views : 2847 | Replies : 0


Cannabis-based drugs may be available on prescription soon

Cannabis-based drugs may be available on prescription soon in Ireland

Image

Cannabis-based medicinal products, such as Sativex, could soon be available to sufferers of Multiple Sclerosis (MS) and other medical conditions on prescription.

This follows confirmation by the Minister for State at the Department of Health, Róisín Shortall, that the department “is examining the issues associated with applying controls, similar to those that apply to other controlled drugs that can be misused, such as morphine ...
Read more : Cannabis-based drugs may be available on prescription soon | Views : 1223 | Replies : 0


Sweden approves medical 'marijuana' spray Sativex for MS

Image

Medicinal cannabis is now available as a prescription medicine in Sweden after the Medical Products Agency (Läkemedelsverket) approved a cannabis-based mouth spray for the treatment of multiple sclerosis (MS).

"This is great news for those who can't get any relief from the most common drugs," said Jan Hillert, an MS researcher at Karolinska Institutet, to the Dagens Nyheter daily.

The agency has said that it plans to closely monitor the prescription of the new ...
Read more : Sweden approves medical 'marijuana' spray Sativex for MS | Views : 3162 | Replies : 0


GW Pharma hopes for FDA approval for cannabis drug Sativex

Image

A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant itself could soon be making their way to pharmacy shelves, according to drug companies, small biotech firms and university scientists.

A British company, GW Pharma, is in advanced clinical trials for the world's first pharmaceutical developed from raw marijuana instead of synthetic ...
Read more : GW Pharma hopes for FDA approval for cannabis drug Sativex | Views : 1361 | Replies : 3




My Doctor's Opinion

Greetings All...

I took various Sativex documents to my GP for her to read and decide if I was a good candidate for the drug.

As I handed them over to her, she said "is this that cannabis spray"?

I said yes, what do you think?

Before I could finish that short question she put her hands up in front of her and backed up quickly (banging into a table).

Anyone watching this would have ...
Read more : My Doctor's Opinion | Views : 9489 | Replies : 19


Sativex® approved in Sweden for treatment of MS spasticity

Image

GW Pharmaceuticals plc today announced that the Medical Products Agency in Sweden has granted regulatory approval for Sativex® (Delta-9-Tetrahydro-cannabinol (THC) and Cannabidiol (CBD)) oromucosal spray as a treatment of moderate to severe spasticity due to MS in patients who have not responded adequately to other anti-spasticity medicationi. Sativex® is a first in class endocannabinoid system modulator and is currently available in the UK, Germany, Spain and Denmark.

Evidence generated from clinical trials shows that ...
Read more : Sativex® approved in Sweden for treatment of MS spasticity | Views : 3338 | Replies : 0


GW Pharma files new regulatory application to expand Sativex

GW Pharma files new regulatory application to expand Sativex® approvals in Europe

Image

GW Pharmaceuticals plc today announced that it has submitted an application under the European Mutual Recognition Procedure (MRP) to seek to expand the marketing authorization for Sativex® to a number of additional European member states.

The new MRP follows successful completion of a previous MRP earlier this year in which recommendation for approval of Sativex® was obtained from regulatory authorities in Germany, ...
Read more : GW Pharma files new regulatory application to expand Sativex | Views : 2967 | Replies : 0


 

Login  •  Register


Statistics

Total posts 240764 • Total topics 26324 • Total members 17539


Contact us | Terms of Service